Table 1. Baseline Subject Characteristics by Treatment Group a-c.
| Characteristic | CR (n = 12) | ADF (n = 13) |
|---|---|---|
| Age (y) | 42.7 (7.9) | 39.6 (9.5) |
|
| ||
| Sex [n, (%)] | ||
| Female | 9 (75%) | 10 (77%) |
| Male | 3 (25%) | 3 (23%) |
|
| ||
| Ethnicity [n, (%)] | ||
| Hispanic/Latino | 3 (25%) | 4 (31%) |
| Not Hispanic/Latino | 8 (67%) | 8 (62%) |
| Unknown | 1 (8%) | 1 (8%) |
|
| ||
| Race [n, (%)] | ||
| White | 10 (83%) | 8 (62%) |
| Black/African American | 0 (0%) | 1 (8%) |
| Multiracial Origin | 0 (0%) | 2 (15%) |
| Unknown | 2 (17%) | 2 (15%) |
|
| ||
| Anthropometric Measures | ||
| Weight (kg) ** | 114.0 (20.0) | 94.7 (10.6) |
| BMI (kg/m2) | 39.5 (6.0) | 35.8 (3.7) |
| Total Fat Mass (kg) ** | 48.8 (10.4) | 37.7 (8.1) |
| Trunk Fat Mass (kg) * | 26.0 (6.0) | 20.9 (6.2) |
| Total Lean Mass (kg) | 60.9 (11.5) | 53.2 (8.8) |
|
| ||
| Metabolic Measures | ||
| Cholesterol (mg/dL) | 171.3 (36.4) | 166.9 (33.2) |
| Total Direct HDL (mg/dL) | 38.9 (7.2) | 38.2 (8.1) |
| LDL (mg/dL) | 104.5 (28.8) | 100.0 (30.7) |
| Triglycerides (mg/dL) | 139.6 (43.2) | 142.9 (56.2) |
| Glucose (mg/dL) | 91.6 (7.8) | 88.4 (6.5) |
| Insulin (μU/mL) * | 19.3 (5.8) | 13.3 (6.0) |
| Si (× 104 μU/(mL min)) | 2.8 (4.6) | 1.9 (1.3) |
| Leptind (ng/mL) | 30.5 (11.8) | 29.8 (11.6) |
| Ghrelind (pg/mL) | 810.3 (229.6) | 767.5 (126.1) |
| BDNF(pg/mL) | 22552.1 (5695.5) | 20934.6 (7505.8) |
| RMR (kcal/day) * | 1892.5 (265.1) | 1640.1 (202.8) |
a
Fisher's exact test analyses completed for gender, ethnicity, and race. Number (%) all such values. Significance indicated by
*
p <0.05,
**
p<0.01.
b
Satterthwaite independent-samples t-test analyses completed for all continuous variables. Mean (SD) all such values.
c
Body Mass Index (BMI); High-density lipoprotein (HDL); Low-density lipoprotein (LDL); Insulin Sensitivity Index (SI); Brain-derived neurotrophic factor (BDNF); Resting Metabolic Rate (RMR).
d
n=12 in ADF group.